Project Grant F31DA062471
- The National Institute on Drug Abuse (NIDA), through the Drug Use and Addiction Research Programs (CFDA 93.279), has awarded a $684,694 Cooperative Agreement to New York University (NYU) to develop and evaluate a novel home-based intervention combining transcranial direct current stimulation (tDCS) with mindfulness meditation for the treatment of cannabis use disorder (CUD). The project, titled "Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $249,108 to Brown University to conduct a multimodal study examining the relationship between cannabis use, trauma, and self-regulatory cognitive processes in emerging adults aged 18-25. The study leverages methodology from a parent NIDA-funded project (R01DA054116) to recruit 70 participants and implement additional self-report and behavioral task...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $357,806 to the Trustees of Indiana University to conduct research on neuroimaging of instrumental learning networks in adolescent cannabis use treatment. The key objectives are to: 1) identify associations between cannabis use disorder symptomatology and neural activity during instrumental learning, and 2) examine whether neural activity...
- This Cooperative Agreement award of $3,119,619 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research to evaluate the effects of combining contingency management (CM) with deep transcranial magnetic stimulation (deep TMS) for the treatment of cocaine use disorder (CUD). The study aims to target brain circuitry alterations associated with CM response to improve treatment outcomes for individuals with CUD, a population that has seen...
- This $674,709 Project Grant awarded on July 15, 2025 by the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports research aimed at understanding the neural mechanisms underlying the effects of continuous theta burst stimulation (cTBS) on inhibitory control and craving regulation in nicotine addiction. The research, conducted by the University of Missouri System, involves a location control crossover study examining how cTBS...
- This $1,672,696 project grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to identify the computational and neurophysiological mechanisms underlying the interplay between craving and decision-making in cannabis use disorders. The project will deploy a paradigm to assess craving and decision-making across two independent samples of cannabis users (online: n=1,000; in-person: n=100) and implement a joint modeling...
- This $1,585,991 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a study to evaluate the use of transcranial direct current stimulation (tDCS) combined with cognitive reappraisal training to reduce craving and cue-reactivity in individuals with cocaine use disorder. The study will conduct a double-blind randomized trial with four groups (n=120 total) to assess the synergistic effects of real vs....
- This federal Project Grant award of $197,640 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development and pilot testing of AMP-C, a digital therapeutic targeting reward dysfunction in individuals with co-occurring cannabis use disorder (CUD) and major depressive disorder (MDD). The principal investigator, Dr. Collins, will conduct a randomized controlled trial to evaluate the accessibility, feasibility, and...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $498,002 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Illinois to conduct a study aimed at increasing alcohol abstinence in young adults with alcohol use disorder (AUD). The overall goals of this 3-year project are to: (1) test the efficacy of combining contingency management (CM) with problem-solving therapy (CM-PST) versus CM alone in a 2-arm pilot randomized controlled trial, and...
EXPERIMENTAL MANIPULATION OF THE EMOTIONAL SALIENCE OF CANNABIS USE-RELATED INFORMATION - PROJECT SUMMARY GIVEN THE RISING PREVALENCE OF DAILY CANNABIS USE, THE TREMENDOUS PUBLIC HEALTH BURDEN OF CANNABIS USE DISORDER (CUD), AND THE LOW TREATMENT-SEEKING RATES IN PEOPLE WITH CUD, IT IS BECOMING INCREASINGLY IMPORTANT TO UNDERSTAND THE MECHANISMS THROUGH WHICH DISORDERED USE IS MAINTAINED AND RECOVERY IS THWARTED. RECOGNIZING AND GIVING CREDENCE TO THE NEGATIVE CONSEQUENCES OF CHRONIC DRUG USE IS A VITAL PREREQUISITE FOR BEHAVIOR CHANGE. EMERGING EVIDENCE SUGGESTS THAT THE CLOSELY CONNECTED MEDIAL ORBITOFRONTAL CORTEX (MOFC) AND ROSTRAL ANTERIOR CINGULATE CORTEX (RACC) ARE KEY NEUROBIOLOGICAL SUBSTRATES INVOLVED IN THESE PROCESSES. A NEURAL MEASURE RELATED TO MOFC ACTIVITY, ALONG WITH MOFC ITSELF, HAVE BEEN IMPLICATED IN THE PROCESSING OF SELF-REFERENTIAL SUBSTANCE USE-RELATED STATEMENTS. FURTHER, ALTERED OFC AND RACC CONNECTIVITY WAS ASSOCIATED WITH DENIAL OF SUBSTANCE-RELATED PROBLEMS, WHILE RACC ACTIVATION WAS INVERSELY CORRELATED WITH PERCEIVED NEED TO CHANGE SUBSTANCE USE. ADDITIONALLY, A NEURAL SIGNAL RELATED TO ACC ACTIVITY WAS ALTERED IN INDIVIDUALS WITH SEVERE CUD WHO HAD REDUCED SELF-AWARENESS OF THEIR BEHAVIOR DURING A DRUG CHOICE TASK. ALTOGETHER, THESE STUDIES POINT TO ABERRANT MOFC/RACC ACTIVITY AND CONNECTIVITY, THOUGH THE STUDIES HAVE BEEN LIMITED BY THEIR LOW PREVALENCE AND CORRELATIONAL NATURE, SUGGESTING THE NEED FOR CAUSAL TESTING OF MOFC/RACC'S INVOLVEMENT IN THESE IMPORTANT PROCESSES. THETA BURST STIMULATION (TBS), A TYPE OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS), IS A SAFE AND EFFECTIVE OPTION FOR ACUTE NONINVASIVE CAUSAL MANIPULATION OF NEURAL ACTIVITY THAT HAS SUCCESSFULLY INDUCED NEURAL AND BEHAVIORAL EFFECTS AFTER A SINGLE SESSION OF STIMULATION. THE PROPOSED PROJECT WAS CONCEPTUALIZED AND DESIGNED TO PROVIDE TRAINING IN TMS METHODOLOGY, MAGNETIC RESONANCE IMAGING (MRI) AND FUNCTIONAL MRI (FMRI) METHODOLOGIES, AND EXPERIMENTAL TASK DEVELOPMENT PERTAINING TO ADDICTION INSIGHT THEORY TO THE APPLICANT, ALONG WITH FURTHER PROFESSIONAL DEVELOPMENT THAT WILL HELP ACCELERATE HIS CAREER GOALS AS AN INDEPENDENT CLINICAL SCIENTIST. APPROXIMATELY 34 INDIVIDUALS WITH SEVERE CUD RECRUITED TO THE PROPOSED STUDY WILL BE RANDOMIZED TO RECEIVE EITHER CONTINUOUS TBS (CTBS) OR INTERMITTENT TBS (ITBS), ALONG WITH SHAM TBS. SPECIFIC AIM 1 INVOLVES LOCALIZING THE EFFECTS OF TBS IN TERMS OF CHANGES TO CEREBRAL BLOOD FLOW TO MOFC OR OTHER AREAS ENGAGED THROUGH THE TBS MANIPULATION. SPECIFIC AIM 2 WILL TEST MOFC AS A NEURAL MECHANISM INVOLVED IN CANNABIS USE PROBLEM RECOGNITION USING AN IMPROVED VERSION OF OUR PREVIOUSLY VALIDATED AUDITORY SELF-REFERENTIAL PROCESSING TASK. FINALLY, SPECIFIC AIM 3 WILL DETERMINE IF MOFC MODULATION AFFECTS BEHAVIORAL CHOICE INSIGHT IN DRUG CHOICE CONTEXTS DURING OUR PREVIOUSLY VALIDATED PROBABILISTIC CHOICE TASK. THE RESULTS FROM THIS NOVEL AND RIGOROUS PROJECT WILL PROVIDE CRITICAL KNOWLEDGE OF THE NEUROBIOLOGICAL MECHANISMS UNDERLYING THE PROCESSING OF DRUG USE-RELATED SELF-REFERENTIAL INFORMATION, WHICH COULD INFORM FUTURE INTERVENTIONS TO IMPROVE INSIGHT INTO SUBSTANCE USE DISORDERS AND OTHER MALADAPTIVE BEHAVIORS AND INCREASE TREATMENT-SEEKING RATES FOR A DEBILITATING SET OF DISORDERS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $43.1k | 5/30/25 |